These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
299 related items for PubMed ID: 37787114
21. KLS-13019, a Novel Structural Analogue of Cannabidiol and GPR55 Receptor Antagonist, Prevents and Reverses Chemotherapy-Induced Peripheral Neuropathy in Rats. Ippolito M, Hayduk SA, Kinney W, Brenneman DE, Ward SJ. J Pharmacol Exp Ther; 2024 Oct 18; 391(2):231-240. PubMed ID: 39134424 [Abstract] [Full Text] [Related]
23. Meclizine and Metabotropic Glutamate Receptor Agonists Attenuate Severe Pain and Ca2+ Activity of Primary Sensory Neurons in Chemotherapy-Induced Peripheral Neuropathy. Shannonhouse J, Bernabucci M, Gomez R, Son H, Zhang Y, Ai CH, Ishida H, Kim YS. J Neurosci; 2022 Aug 03; 42(31):6020-6037. PubMed ID: 35772967 [Abstract] [Full Text] [Related]
24. Protease-Activated Receptor 2 (PAR2) Expressed in Sensory Neurons Contributes to Signs of Pain and Neuropathy in Paclitaxel Treated Mice. Kume M, Ahmad A, DeFea KA, Vagner J, Dussor G, Boitano S, Price TJ. J Pain; 2023 Nov 03; 24(11):1980-1993. PubMed ID: 37315729 [Abstract] [Full Text] [Related]
25. Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy. Joseph EK, Chen X, Bogen O, Levine JD. J Pain; 2008 May 03; 9(5):463-72. PubMed ID: 18359667 [Abstract] [Full Text] [Related]
27. Identification of a functional interaction of HMGB1 with Receptor for Advanced Glycation End-products in a model of neuropathic pain. Allette YM, Due MR, Wilson SM, Feldman P, Ripsch MS, Khanna R, White FA. Brain Behav Immun; 2014 Nov 03; 42():169-77. PubMed ID: 25014009 [Abstract] [Full Text] [Related]
30. Dorsal root ganglion neurons become hyperexcitable and increase expression of voltage-gated T-type calcium channels (Cav3.2) in paclitaxel-induced peripheral neuropathy. Li Y, Tatsui CE, Rhines LD, North RY, Harrison DS, Cassidy RM, Johansson CA, Kosturakis AK, Edwards DD, Zhang H, Dougherty PM. Pain; 2017 Mar 03; 158(3):417-429. PubMed ID: 27902567 [Abstract] [Full Text] [Related]
32. Second messengers mediating high-molecular-weight hyaluronan-induced antihyperalgesia in rats with chemotherapy-induced peripheral neuropathy. Bonet IJM, Staurengo-Ferrari L, Araldi D, Green PG, Levine JD. Pain; 2022 Sep 01; 163(9):1728-1739. PubMed ID: 34913881 [Abstract] [Full Text] [Related]
33. Involvement of high mobility group box 1 in the development and maintenance of chemotherapy-induced peripheral neuropathy in rats. Nishida T, Tsubota M, Kawaishi Y, Yamanishi H, Kamitani N, Sekiguchi F, Ishikura H, Liu K, Nishibori M, Kawabata A. Toxicology; 2016 Jul 15; 365():48-58. PubMed ID: 27474498 [Abstract] [Full Text] [Related]
35. Induction of monocyte chemoattractant protein-1 (MCP-1) and its receptor CCR2 in primary sensory neurons contributes to paclitaxel-induced peripheral neuropathy. Zhang H, Boyette-Davis JA, Kosturakis AK, Li Y, Yoon SY, Walters ET, Dougherty PM. J Pain; 2013 Oct 15; 14(10):1031-44. PubMed ID: 23726937 [Abstract] [Full Text] [Related]
36. Nociceptor Translational Profiling Reveals the Ragulator-Rag GTPase Complex as a Critical Generator of Neuropathic Pain. Megat S, Ray PR, Moy JK, Lou TF, Barragán-Iglesias P, Li Y, Pradhan G, Wanghzou A, Ahmad A, Burton MD, North RY, Dougherty PM, Khoutorsky A, Sonenberg N, Webster KR, Dussor G, Campbell ZT, Price TJ. J Neurosci; 2019 Jan 16; 39(3):393-411. PubMed ID: 30459229 [Abstract] [Full Text] [Related]
37. TRPA1 modulation by Sigma-1 receptor prevents oxaliplatin-induced painful peripheral neuropathy. Marcotti A, Fernández-Trillo J, González A, Vizcaíno-Escoto M, Ros-Arlanzón P, Romero L, Vela JM, Gomis A, Viana F, de la Peña E. Brain; 2023 Feb 13; 146(2):475-491. PubMed ID: 35871491 [Abstract] [Full Text] [Related]
38. Hyperbaric Oxygen Therapy Alleviates Paclitaxel-Induced Peripheral Neuropathy Involving Suppressing TLR4-MyD88-NF-κB Signaling Pathway. Wang SH, Huang SH, Hsieh MC, Lu IC, Chou PR, Tai MH, Wu SH. Int J Mol Sci; 2023 Mar 11; 24(6):. PubMed ID: 36982452 [Abstract] [Full Text] [Related]
39. Selective HCN1 block as a strategy to control oxaliplatin-induced neuropathy. Resta F, Micheli L, Laurino A, Spinelli V, Mello T, Sartiani L, Di Cesare Mannelli L, Cerbai E, Ghelardini C, Romanelli MN, Mannaioni G, Masi A. Neuropharmacology; 2018 Mar 15; 131():403-413. PubMed ID: 29339292 [Abstract] [Full Text] [Related]
40. Chemotherapy-induced peripheral neuropathy-part 2: focus on the prevention of oxaliplatin-induced neurotoxicity. Sałat K. Pharmacol Rep; 2020 Jun 15; 72(3):508-527. PubMed ID: 32347537 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]